Ariviya, a Nanotechnology Biotechnology Startup founded by Dr. Siva, from a small town Pattukkottai in the State of Tamil Nadu, India, has developed a product called MammaryO to prevent ‘Mastitis’ in dairy cows. Ariviya, in a press release, has said that the company has attracted global investors’ attention at  the recently held Tamil Nadu Global Investors Meet 2019.

Bovine mastitis is an expensive problem for dairy farmers all over the world. According to Food and Agriculture Organization of the United Nations Report "Impact of Mastitis in Small Scale Dairy Production Systems," annual loss due to Mastitis is 2 billion USD in the US, 1.5 billion USD in Europe and 2.2 billion USD in India.

According to "University of Illinois Extension – Illini DairyNet" and "Foundation Agricounsel Research Study – U.S. Dairy Mastitis Market," Mastitis reduces milk production in the US by 11% and in India by 21%. Mastitis causes 70% of all avoidable losses during milk production. According to article published in "A Summary of the Reasons Why Farmers Cull Cows" journalofdairyscience.org, Mastitis is ranked second after infertility as the main reason for culling (slaughtering) cows. 20-50% of dairy cows treated for Mastitis in Europe and the USA.

Commenting about the product, Dr. Siva, Chief Technology Officer of Ariviya, said, “MammaryO is a natural, organic, thick Nano-Bio liquid foam covering and protecting the cow teats from bacterial infection and reduces the spread of organism which may cause Bovine Mastitis, lasts long enough in the cow teat until next milking, easily washable and biodegradable.”

It is believed that the price per gallon increases if there would be lesser number of Somatic Cell Count(SCC) in the milk, but if the cow has Mastitis then this SCC number also increases, and the price per gallon is reduced respectively. Thus, preventing mastitis would improve the milk quality and also increase the business.

The current mastitis treatment is very inefficient. Mastitis is detected from visible swelling, abnormal milk, and rise in somatic cell count. Sick cows get separated from the rest of the cows for weeks then they undergo antibiotic treatment. For a long period, the cow can’t be milked because the antibiotics are unsafe for human consumption.

Ariviya, a Nanotechnology Biotechnology Startup founded by Dr. Siva,has developed a product called MammaryO to prevent ‘Mastitis’ in dairy cows.